Lidocaine/prilocaine gel

Drug Profile

Lidocaine/prilocaine gel

Alternative Names: Oraqix

Latest Information Update: 02 Oct 2009

Price : $50

At a glance

  • Originator DENTSPLY International
  • Class Acetanilides; Anilides; Erectile dysfunction therapies; Local anaesthetics; Small molecules
  • Mechanism of Action Opioid receptor agonists; Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Dental pain

Most Recent Events

  • 14 Oct 2004 Launched for Dental pain in USA (Topical)
  • 14 Oct 2004 DENTSPLY has entered into an exclusive distribution agreement with OraPharma for the sale of ldocaine/prilocaine gel in USA
  • 01 Apr 2004 Preregistration for Dental pain in Austria (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top